Ascendis Pharma A/S (ASND) Earnings Date & Reports
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more
ASND is expected to report earnings to fall 71.89% to 79 cents per share on November 11
Q3'26
Est.
$0.80
Q2'26
Beat
by $1.32
Q1'26
Beat
by $0.09
Q4'25
Missed
by $0.40
Q3'25
Missed
by $0.72
The last earnings report on August 13 showed earnings per share of $2.83, beating the estimate of $1.51. With 167.02K shares outstanding, the current market capitalization sits at 15.13B.